Moderna Inc. diskutieren
Moderna (MRNA) had its price target raised by Bank of America Corporation from $34.00 to $38.00. They now have an "underperform" rating on the stock.
Ratings data for MRNA provided by MarketBeat
Moderna (MRNA) had its "overweight" rating reaffirmed by UBS Group AG.
Ratings data for MRNA provided by MarketBeat
Moderna (MRNA) had its "overweight" rating reaffirmed by Piper Sandler.
Ratings data for MRNA provided by MarketBeat
Moderna (MRNA) was upgraded by William Blair from "market perform" to "outperform".
Ratings data for MRNA provided by MarketBeat



Neueste Beiträge
Citigroup_Inc_ in Lucid Group Inc. diskutieren